![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » DiaSorin Earns CE Mark for Flu Assay to Run with COVID-19 Test
DiaSorin Earns CE Mark for Flu Assay to Run with COVID-19 Test
DiaSorin has earned a CE Mark for its Simplexa Flu A/B and respiratory syncytial virus (RSV) Direct Gen II assay kit.
The flu test can be run on its own or alongside the company’s Simplexa COVID-19 Direct kit. The assay runs on DiaSorin’s Liaison MDX system.
Viral infections caused by Flu A, Flu B, RSV and SARS-CoV-2 have similar clinical presentations, but the treatment options are different, the company noted.
Upcoming Events
-
11Jul
-
18Jul
-
21Oct